MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$121,974K
EPS
-$1.69
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
Research and development
86,011 45,838* 56,473
General and administrative
39,121 17,840* 27,459
Total operating expenses
125,132 63,678 83,932
Loss from operations
-125,132 -63,678* -83,932
Interest income
6,355 7,271* 5,736
Interest expense
1,823 1,651* 1,960
Other (expense) income, net
-432 -678* -137
Total other income, net
4,100 4,942* 3,639
Loss before provision for income taxes
--58,736* -
Provision for income taxes
-0* -
Net loss
-121,032 -58,736* -80,293
Change in unrealized losss and gaines on marketable securities
-942 -669* 354
Comprehensive loss
-121,974 -59,405 -79,939
Basic EPS
-1.69 -0.919 -1.26
Diluted EPS
-1.69 -0.919 -1.26
Basic Average Shares
71,476,595 64,620,573 63,847,055
Diluted Average Shares
71,476,595 64,620,573 63,847,055
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$121,974K Interest income$6,355K Net loss-$121,032K Change in unrealizedlosss and gaines on...-$942K Total other income,net$4,100K Interest expense$1,823K Other (expense)income, net-$432K Loss from operations-$125,132K Total operatingexpenses$125,132K Research and development$86,011K General andadministrative$39,121K

Vera Therapeutics, Inc. (VERA)

Vera Therapeutics, Inc. (VERA)